FBLG Latest Press Releases

-- October 19, 2026 --

FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting PRNewswire 8:31 AM

-- October 14, 2026 --

FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs PRNewswire 8:31 AM

-- October 7, 2026 --

FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body PRNewswire 8:30 AM

-- September 29, 2026 --

FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity PRNewswire 8:30 AM

-- September 17, 2026 --

FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer PRNewswire 8:30 AM

-- September 3, 2026 --

FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing PRNewswire 8:30 AM

-- September 1, 2026 --

FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media PRNewswire 8:30 AM

-- August 27, 2026 --

FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial PRNewswire 8:31 AM

-- August 26, 2026 --

FibroBiologics Regains Compliance with Nasdaq Trading Rules PRNewswire 8:30 AM

-- August 24, 2026 --

FibroBiologics Appoints Leigh Steinberg to Board of Directors PRNewswire 8:30 AM

-- August 20, 2026 --

FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease PRNewswire 8:30 AM

-- August 18, 2026 --

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints PRNewswire 8:30 AM

-- August 11, 2026 --

FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets PRNewswire 8:30 AM

-- August 5, 2026 --

FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage PRNewswire 8:30 AM

-- July 31, 2026 --

FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate PRNewswire 5:35 PM

-- July 9, 2026 --

FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors PRNewswire 8:30 AM

-- July 7, 2026 --

FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial PRNewswire 8:31 AM

-- June 30, 2026 --

FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference PRNewswire 8:30 AM

-- June 29, 2026 --

FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules PRNewswire 4:01 PM

-- June 26, 2026 --

FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules PRNewswire 8:30 AM

-- June 22, 2026 --

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing Globe Newswire 8:30 AM

-- June 16, 2026 --

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes